IP Library › Assignment 044019/0252
Patent Assignment
Reel/Frame 044019/0252

Assignment of Assignor's Interest

Recorded: 2017-11-02 Pages: 7
Assignors
HEARTLEIN, MICHAEL
Executed: 2016-12-05
DEROSA, FRANK
Executed: 2016-12-05
SMITH, LIANNE
Executed: 2016-12-12
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property (1)
Messenger RNA Therapy for the Treatment of Ornithine Transcarbamylase Deficiency
Application: 15/621,616 →
Publication: US 2018/0008680
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 2, 2017
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: RANA THERAPEUTICS, INC.
Reel/Frame 044353/0922 →
Change of Name Nov 2, 2017
From: RANA THERAPEUTICS, INC.
To: TRANSLATE BIO, INC.
Reel/Frame 044354/0009 →
Assignment of Assignor's Interest Jan 25, 2018
From: DEROSA, FRANK; HEARTLEIN, MICHAEL; SMITH, LIANNE; KARVE, SHRIRANG
To: TRANSLATE BIO MA, INC.
Reel/Frame 044732/0044 →
Assignment of Assignor's Interest Sep 3, 2020
From: TRANSLATE BIO MA, INC.
To: TRANSLATE BIO, INC.
Reel/Frame 053685/0346 →